Research and Development Funding and Horizon Europe

Andy Slaughter Excerpts
Tuesday 18th April 2023

(1 year, 6 months ago)

Westminster Hall
Read Full debate Read Hansard Text Read Debate Ministerial Extracts

Westminster Hall is an alternative Chamber for MPs to hold debates, named after the adjoining Westminster Hall.

Each debate is chaired by an MP from the Panel of Chairs, rather than the Speaker or Deputy Speaker. A Government Minister will give the final speech, and no votes may be called on the debate topic.

This information is provided by Parallel Parliament and does not comprise part of the offical record

Andy Slaughter Portrait Andy Slaughter (Hammersmith) (Lab)
- Hansard - -

I congratulate my hon. Friend the Member for Sheffield Central (Paul Blomfield) on his excellent speech, and on getting this debate, which is relevant and pertinent, given what the Government are saying but not doing on this subject. I want to use my few minutes to talk about Imperial College London. Hon. Members will be familiar with Imperial; it is consistently one of the world’s top universities and is of great standing. It has been around for more than a century and leads in fields of science, engineering, medicine and business. If I can be slightly parochial, it also has the new White City campus, which is of much more recent origin, but which is already an innovation district. It has an industrial strategy jointly with Hammersmith and Fulham Council. It is a major employer, builder and investor in the area, and it is developing world-leading research on quantum engineering, clean energy, machine learning and clinical trials on dementia, infectious diseases, cancer and many other matters. This is absolute cutting edge, but like many of our leading universities, Imperial relies on Horizon, and has done over a long period. I will explain what that means and why the Government’s solutions are simply not adequate to the task.

UK universities have built high-impact science and innovation networks over more than three decades of collaboration within EU framework programmes. Those deep-seated networks aid the flow of ideas, talent and funding that underpins the UK’s leading science base. Imperial was a partner on collaborative Horizon 2020 research projects worth more than €2.2 billion over the course of the programme. That means that in addition to direct funding, it had access to the data, infrastructure and knowledge generated through the wider project consortia. On average across all its collaborative Horizon 2020 projects, Imperial received access to world-class research consortia that had funding at a scale of 27 times its own financial awards. Those projects averaged 16 partner organisations, which developed networks and shared research expertise. On average, over eight large-scale collaborative Horizon 2020 projects with a budget of more than €50 million, Imperial accessed world-class research consortia with funding that was at a scale of 280 times its own financial award, and those projects averaged 94 co-collaborating organisations. Hon. Members can take my word for it, but we also heard a lengthy intervention from the right hon. Member for Ludlow (Philip Dunne) about one of those Imperial projects and its success.

We are not just talking about regenerating a whole district of London, and about a top UK university; we are talking about enabling British science and technology to compete with the US. The quality of the national ecosystem and the way it leverages in the wider EU ecosystem allows us to achieve scale through partnership. About 60% of Imperial’s research papers with a US collaborator also have a European co-author, as do 68% of research papers with Canada and 83% with Brazil. Imperial told me in advance of this debate:

“Outside Horizon Europe, the UK is in real danger of ceding our hard-won position in the global R&D hierarchy and becoming less attractive as a research partner and less attractive for foreign direct investment. As part of Horizon Europe, the UK can influence the future direction of billions of pounds worth of research investment to more closely align with UK strategic priorities.”

That is what is at risk.

Already, R&D investment in the UK is little more than half what it is in Japan, the US or Germany. Also, as my hon. Friend the Member for Sheffield Central indicated, the Government’s alternative simply does not address the issues of certainty, longevity or, in particular, leveraging in. It is impossible to replace what is being achieved. This is a real crisis and a fundamental moment of decision for the Government. We have to go back into Horizon; we have to have that access. Our universities are doing absolutely everything they can. They are world-leading. We need a Government who have the vision and understanding to match that.